Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Medinotec (MDNC) Long-Term Debt Issuances (2022 - 2023)

Medinotec posted quarterly Long-Term Debt Issuances of $275087.0 for Q3 2023, down 49.06% year-on-year from $540063.0 in Q3 2022, and up 2039.14% on a QoQ basis from -$14186.0 in Q2 2023.

Medinotec (MDNC) has 2 years of Long-Term Debt Issuances data on file, last reported at $275087.0 in Q3 2023.

  • For the quarter ending Q3 2023, Long-Term Debt Issuances fell 49.06% year-over-year to $275087.0; the trailing twelve-month figure through Aug 2023 stood at -$621667.0 (changed N/A YoY), and the FY2025 full-year result was -$797.0, up 49.81% from the prior year.
  • Long-Term Debt Issuances for Q3 2023 stood at $275087.0, up from -$14186.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $540063.0 in Q3 2022 and bottomed at -$1.2 million in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 19.86 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.71 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.15 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Medinotec - - 854,557.00 -

Historic Data

Download Data 🔒
DateValue
Aug 31, 2023 275,087.00
Aug 31, 2023 275,087.00
May 31, 2023 -14,186.00
May 31, 2023 -14,186.00
Feb 28, 2023 -1.21 Mn
Feb 28, 2023 -1.21 Mn
Nov 30, 2022 328,214.00
Nov 30, 2022 328,214.00
Aug 31, 2022 540,063.00
Aug 31, 2022 540,063.00
May 31, 2022 63,436.00
May 31, 2022 63,436.00
Feb 28, 2022 267,149.00
Feb 28, 2022 267,149.00